Total Payments
$4,854
2024 Payments
$2,395
Companies
21
Transactions
266
Medicare Patients
202
Medicare Billing
$31,001
Payment Breakdown by Category
Food & Beverage$4,757 (98.0%)
Education$96.50 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,757 | 265 | 98.0% |
| Education | $96.50 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,006 | 52 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $537.87 | 27 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $459.19 | 30 | $0 (2024) |
| Lundbeck LLC | $439.19 | 25 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $364.50 | 13 | $0 (2024) |
| ITI, Inc. | $319.79 | 17 | $0 (2023) |
| Alkermes, Inc. | $303.41 | 16 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $295.88 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $225.27 | 16 | $0 (2024) |
| Axsome Therapeutics, Inc. | $217.77 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,395 | 143 | ABBVIE INC. ($508.50) |
| 2023 | $1,517 | 73 | ABBVIE INC. ($343.82) |
| 2022 | $572.83 | 25 | Teva Pharmaceuticals USA, Inc. ($153.11) |
| 2021 | $368.53 | 25 | Sunovion Pharmaceuticals Inc. ($95.82) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: CNS | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: OUD | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Central Nervous System | ||||||
| 10/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: CNS | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.46 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Psychiatry/Psychology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 167 | $25,135 | $9,809 |
| 2022 | 3 | 81 | 269 | $37,500 | $15,235 |
| 2021 | 2 | 69 | 119 | $12,575 | $5,957 |
Total Patients
202
Total Services
555
Medicare Billing
$31,001
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 131 | $24,235 | $9,364 | 38.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 36 | $900.00 | $444.60 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 181 | $33,485 | $13,756 | 41.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 25 | 77 | $1,925 | $959.58 | 49.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 11 | 11 | $2,090 | $519.86 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 60 | $11,100 | $5,214 | 47.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 37 | 59 | $1,475 | $743.40 | 50.4% |
About Megan High
Megan High is a Registered Nurse healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2021. The National Provider Identifier (NPI) number assigned to this provider is 1326627175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Megan High has received a total of $4,854 in payments from pharmaceutical and medical device companies, with $2,395 received in 2024. These payments were reported across 266 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,757).
As a Medicare-enrolled provider, High has provided services to 202 Medicare beneficiaries, totaling 555 services with total Medicare billing of $31,001. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health
- Location Fort Worth, TX
- Active Since 04/07/2021
- Last Updated 04/07/2021
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1326627175
Products in Payments
- VRAYLAR (Drug) $1,006
- CAPLYTA (Drug) $615.67
- REXULTI (Drug) $554.22
- INGREZZA (Drug) $364.50
- Austedo XR (Drug) $318.20
- TRINTELLIX (Drug) $225.27
- Auvelity (Drug) $217.77
- ABILIFY MAINTENA (Drug) $210.07
- ARISTADA (Drug) $191.15
- LATUDA (Drug) $130.84
- SUBLOCADE (Drug) $119.46
- AUSTEDO (Drug) $105.66
- APLENZIN (Drug) $90.55
- FANAPT (Drug) $81.65
- QUVIVIQ (Drug) $78.04
- LYBALVI (Drug) $73.05
- NUEDEXTA (Drug) $71.69
- ABILIFY ASIMTUFII (Drug) $62.40
- SPRAVATO (Drug) $50.54
- JORNAY PM (Drug) $38.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Fort Worth
Mrs. Tamekia Scaggs, Whnp-Bc, WHNP-BC
Registered Nurse — Payments: $47,087
Registered Nurse $47,087
Jessica Thompson, Aprn, APRN
Registered Nurse — Payments: $6,117
Registered Nurse $6,117
Mrs. Dana Savage
Registered Nurse — Payments: $3,855
Registered Nurse $3,855
Amy Kunkel, Aprn, APRN
Registered Nurse — Payments: $3,566
Registered Nurse $3,566
Hilary Booth, Np, NP
Registered Nurse — Payments: $3,388
Registered Nurse $3,388
Deepa Abraham
Registered Nurse — Payments: $2,748
Registered Nurse $2,748